Caroline Litchfield - 02 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP & CFO
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Caroline Litchfield
Issuer symbol
MRK
Transactions as of
02 May 2023
Net transactions value
$0
Form type
4
Filing time
04 May 2023, 18:29:24 UTC
Previous filing
03 May 2023
Next filing
24 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 31,691 02 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +58,783 $0.000000 58,783 02 May 2023 Common Stock 58,783 $117.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.